Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22657344 | 0.81 | — | — | |
| SCHEMBL5496757 | 0.79 | — | — | |
| SCHEMBL16425793 | 0.79 | TSHR (0.40) | MAPK1NPSR1TSHRSMN1; SMN2 | |
| SCHEMBL11003812 | 0.79 | KMT2A (0.36) | MAPK1TSHR | |
| SCHEMBL6933557 | 0.76 | MGAM (0.44) | TSHR | |
| SCHEMBL5827113 | 0.74 | TSHR (0.41) | TSHRSMN1; SMN2 | |
| SCHEMBL31278397 | 0.73 | HAO1 (0.43) | MAPK1NPSR1TSHR | |
| SCHEMBL3821975 | 0.73 | DGAT1 (0.40) | TSHR | |
| SCHEMBL626926 | 0.73 | — | — | |
| SCHEMBL4837194 | 0.73 | KMT2A (0.39) | MAPK1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7595414-B2 | complex capable of being used for chemical vapor deposition of thin metal , or metal oxide films | UBE INDUSTRIES, LTD. (JP) | 2009-09-29 | — | — | US | disclosed |
| US-20080254216-A1 | Metal Complex Compound Comprising B-Diketonato Ligand | UBE INDUSTRIES, LTD. (JP) | 2008-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080254216-A1 | Metal Complex Compound Comprising B-Diketonato Ligand | CAD, APOB, DBI | MAPK1 1729/4885NPSR1 4696/4885TSHR 4087/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.